What is Avalo Therapeutics's debt-to-assets?

Avalo Therapeutics (AVTX) reported debt-to-assets of 0× in Q1 2026.

How has Avalo Therapeutics's debt-to-assets changed year-over-year?

Avalo Therapeutics's debt-to-assets decreased by 43.1% year-over-year, from 0× to 0×.

What is the long-term trend for Avalo Therapeutics's debt-to-assets?

Over 5 years (2020 to 2025), Avalo Therapeutics's debt-to-assets has grown at a -35.6% compound annual growth rate (CAGR), from 0× to 0×.

What does debt-to-assets mean?

Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.

Avalo Therapeutics AVTX Debt-to-assets

Debt-to-assets at other companies

Eli LillyLLY

0.4×-0.1×

AbbVieABBV

0.5×0.0×

XencorXNCR

0.2×0.0×

AbCellera Biologics Inc.ABCL

0.1×+0.1×

AnaptysBio, Inc.ANAB

0×—

Absci CorporationABSI

0×0.0×

Other financials

Income statement

See full

Revenue$59.0K-69.3%

Gross profit$963.0K+8,855%

Operating income-$20.9M-42.5%

Net income-$19.6M-49.3%

EPS (diluted)-$0.98+21.6%

Balance sheet

See full

Cash & equivalents$25.3M-79.8%

Total debt$328.0K-59.1%

Total equity$68.3M-44.3%

Total assets$99.9M-27.9%

Cash flow

See full

Operating cash flow-$17.7M-87.1%

CapEx-—

Free cash flow-$15.0M-444%

Valuation

See full

Market cap$954.59M+1,800%

Enterprise value$929.6M-1,353%

P/S1,909.2×+1,868×

Profitability

See full

Gross margin182%+176pp

Operating margin-15,536.1%-17,275pp

Net margin-7,965.8%-10,750pp

FCF margin-11,123.8%-13,374pp

Returns & leverage

See full

Return on equity-88.8%—

Debt / equity0×0.0×

Current ratio7.7×-14.9×

Where this comes from

Calculated from Avalo Therapeutics’s reported figures.

total debt/total assets=0×

Based on the most recent quarter.

The official record: Avalo Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avalo Therapeutics's debt-to-assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Avalo Therapeutics's debt-to-assets?: Avalo Therapeutics (AVTX) reported debt-to-assets of 0× in Q1 2026.
How has Avalo Therapeutics's debt-to-assets changed year-over-year?: Avalo Therapeutics's debt-to-assets decreased by 43.1% year-over-year, from 0× to 0×.
What is the long-term trend for Avalo Therapeutics's debt-to-assets?: Over 5 years (2020 to 2025), Avalo Therapeutics's debt-to-assets has grown at a -35.6% compound annual growth rate (CAGR), from 0× to 0×.
What does debt-to-assets mean?: Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.